The article discusses the risks of developing prostate cancer in patients taking 5-alpha-reductase inhibitors (5-ARIs) such as dutasteride (Avodart) or finasteride (Proscar). The symptoms as well as the treatment of benign prostatic hyperplasia (BPH) are highlighted. Issues addressed by Harvard ...
A study in the journal Prostate hints towards a molecular mechanism through which a drug—used in the treatment of ALS—could also be used for prostate cancer treatment.
Many men are growing moustaches this month as part of Movember to raise awareness and funds for improving men's health, but do you know where this money goes? Scientists at Bath, funded by Prostate Cancer UK with support from the Movember Foundation, have developed an innovative tool to test...
Levofloxacin or ofloxacin can be used alone if acute epididymitis most likely caused by enteric bacteria (e.g., in men who have undergone prostate biopsy, vasectomy, or other urinary tract instrumentation procedure) and gonorrhea ruled out (e.g., by gram, methylene blue, or gentian violet stai...
Formen—shrinking of the testicles, reduced sperm count, infertility, baldness, development of breasts, increased risk for prostate cancer Forwomen—growth of facial hair, male-pattern baldness, changes in or cessation of the menstrual cycle, enlargement of the clitoris, deepened voice ...
Lifestyle interventions constitute the initial strategy for the primary and secondary prevention of cardiovascular disease in women. However, pharmacothera
By Dennis Thompson HealthDay Reporter THURSDAY, Nov. 7, 2024 -- Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new study finds.Surgery for prostate cancers increases a man’s risk of urinary or sexual complications more than...
Prostate Cancer Screening, Clinical Outcomes for Cancer Drugs Granted Accelerated Approval, Lupus Review, and more Editor’s Summary by Anne Rentoumis Cappola, MD, ScM, Associate Editor of JAMA, the Journal of the American Medical Association, for the May 7, 2024, issue....
Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review. Bonekey Rep. 2015;4:716. Article CAS PubMed PubMed Central Google Scholar Erbağ G, Uygun K, Binnetoğlu E, et al. Aromatase inhibitor treatment for breast cancer: short-term effect on bone ...
For instance, in the book Bottom Line's Health Breakthroughs 2007 Bottom Line Health addresses the risks and benefits of surgery: "The most common treatment for prostate cancer is removal of the prostate gland, but clinical studies show that the operation is of little benefit to men who have ...